Literature DB >> 11986135

A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.

Lynn E DeLisi1, Sarah H Shaw, Timothy J Crow, Gail Shields, Angela B Smith, Veronica W Larach, Nigel Wellman, Josephine Loftus, Betsy Nanthakumar, Kamran Razi, John Stewart, Margherita Comazzi, Antonio Vita, Thomas Heffner, Robin Sherrington.   

Abstract

OBJECTIVE: Some genome-wide scans and association studies for schizophrenia susceptibility genes have yielded significant positive findings, but there is disagreement between studies on their locations, and no mutation has yet been found in any gene. Since schizophrenia is a complex disorder, a study with sufficient power to detect a locus with a small or moderate gene effect is necessary.
METHOD: In a genome-wide scan of 382 sibling pairs with a diagnosis of schizophrenia or schizoaffective disorder, 396 highly polymorphic markers spaced approximately 10 centimorgans apart throughout the genome were genotyped in all individuals. Multipoint nonparametric linkage analysis was performed to evaluate regions of the genome demonstrating increased allele sharing, as measured by a lod score.
RESULTS: Two regions with multipoint maximum lod scores suggesting linkage were found. The highest lod scores occurred on chromosome 10p15-p13 (peak lod score of 3.60 at marker D10S189) and the centromeric region of chromosome 2 (peak lod score of 2.99 at marker D2S139). In addition, a maximum lod score of 2.00 was observed with marker D22S283 on chromosome 22q12, which showed evidence of an imprinting effect, whereby an excess sharing of maternal, but not paternal, alleles was present. No evidence of linkage was obtained at several locations identified in previous studies, including chromosomes 1q, 4p, 5p-q, 6p, 8p, 13q, 15p, and 18p.
CONCLUSIONS: The findings of this large genome-wide scan emphasize the weakness and fragility of linkage reports on schizophrenia. No linkage appears to be consistently replicable across large studies. Thus, it has to be questioned whether the genetic contribution to this disorder is detectable by these strategies and the possibility raised that it may be epigenetic, i.e., related to gene expression rather than sequence variation. Nevertheless, the positive findings on chromosome 2, 10, and 22 should be pursued further.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986135     DOI: 10.1176/appi.ajp.159.5.803

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  67 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting.

Authors:  Ari Karason; Johann E Gudjonsson; Ruchi Upmanyu; Arna A Antonsdottir; Valdimar B Hauksson; E Hjaltey Runasdottir; Hjortur H Jonsson; Daniel F Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Helgi Valdimarsson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

Review 3.  Molecular genetics of schizophrenia: a critical review.

Authors:  Neeraj Berry; Vaidehi Jobanputra; Hemraj Pal
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 4.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

5.  Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- mice.

Authors:  Malolan S Rajagopalan; Brandon Stone; Jean-Claude Rwigema; Umar Salimi; Michael W Epperly; Julie Goff; Darcy Franicola; Tracy Dixon; Shaonan Cao; Xichen Zhang; Bettina M Buchholz; Anthony J Bauer; Serah Choi; Christopher Bakkenist; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

6.  Subcortical structure alterations impact language processing in individuals with schizophrenia and those at high genetic risk.

Authors:  Xiaobo Li; Margaret Black; Shugao Xia; Chenyang Zhan; Hilary C Bertisch; Craig A Branch; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2015-09-18       Impact factor: 4.939

7.  fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk.

Authors:  Xiaobo Li; Craig A Branch; Babak A Ardekani; Hilary Bertisch; Chindo Hicks; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2007-08-24       Impact factor: 4.939

8.  Early detection of schizophrenia by diffusion weighted imaging.

Authors:  Lynn E DeLisi; Kamila U Szulc; Hilary Bertisch; Magda Majcher; Kyle Brown; Arthika Bappal; Craig A Branch; Babak A Ardekani
Journal:  Psychiatry Res       Date:  2006-10-27       Impact factor: 3.222

9.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

Review 10.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.